Comparison of handling and acceptability of two spacer devices in young children with asthma

This study compared parents' preference for two spacer devices, NebuChamber® and Babyhaler® for the treatment of young children with asthma. In this open, cross‐over study 141 patients (aged 5–57 mo) who used inhaled steroids via a spacer device were randomized to budesonide via NebuChamber or...

Full description

Saved in:
Bibliographic Details
Published in:Acta Paediatrica 2001-02, Vol.90 (2), p.133-136
Main Authors: Brand, PLP, van der Baan-Slootweg, OH, Heynens, JWCM, Vries, TW de, Versteegh, FGA, Vreuls, RCFM, den Ouden, WJ, Smit, FJ
Format: Article
Language:English
Subjects:
Aerosols - administration & dosage
Aerosols - therapeutic use
Asthma
Asthma - drug therapy
Babyhaler
Biological and medical sciences
Bronchodilator Agents - administration & dosage
Bronchodilator Agents - therapeutic use
Child, Preschool
Cross-Over Studies
Drug Delivery Systems
Female
Filtration - instrumentation
Humans
Infant
Male
Masks
Medical sciences
NebuChamber
Nebulizers and Vaporizers
Pharmacology. Drug treatments
preference
Respiratory system
spacer device
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study compared parents' preference for two spacer devices, NebuChamber® and Babyhaler® for the treatment of young children with asthma. In this open, cross‐over study 141 patients (aged 5–57 mo) who used inhaled steroids via a spacer device were randomized to budesonide via NebuChamber or beclomethasone dipropionate via Babyhaler. Both treatments were given by the parents twice daily for 2 wk. At the final visit parents completed a questionnaire on preference in general and for a given set of features. Acceptability and handling were scored in a diary. Diary scores on acceptability by the child and handling of both spacer devices were comparable. In the preference questionnaire, 68% of parents preferred NebuChamber [95% confidence interval (CI) 60–76] and 25% Babyhaler (95% CI 18–33). The preference was independent of the type of spacer used before the study and was also apparent in the different features: acceptability by child, carrying around, cleaning, close fitting of face mask, assembling and disassembling, damage resistance and size. These differences were statistically significant for all features, except for acceptability by the child. Conclusion: Two‐thirds of parents prefer NebuChamber over Babyhaler for the treatment of their young asthmatic children.
ISSN:0803-5253
1651-2227
DOI:10.1111/j.1651-2227.2001.tb00273.x